Enlansibumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enlansibumab, covering 2025-05-21 to 2025-05-21. Get the full timeline:
Most recent: Clinical Trial Update: A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer [Phase 2]